Millionaire Mukesh Ambani is now intending to step into the realm of 'Genome Testing'. By collaborating with successful American businesses like 23andMe, Ambani hopes to increase the accessibility and comprehensiveness of healthcare trends in India's expanding consumer market. According to Ramesh Hariharan, CEO of Strand Life Sciences Pvt., the energy-to-ecommerce company would introduce a full Rs 12,000 ($145) genome sequencing test kit in the coming weeks. The company that made this is Strand Life Sciences. Describing how the Bengaluru-based company was acquired by Reliance Industries Ltd. in 2021, and that company now owns around 80% of it, Reliance Industries Ltd. is headed by Asia's richest man.